---

(see:Startup uses phone, light and AI to detect cervical cancer)Israeli startup MobileODT has created the Eva System, which uses an Automated Visual Evaluation (AVE) algorithm that it says can detect cervical cancer by simply examining an image of the cervix (Courtesy) Israeli startup MobileODT has created the Eva System, which uses an Automated Visual Evaluation (AVE) algorithm that it says can detect cervical cancer by simply examining an image of the cervix (Courtesy) Israeli start-up MobileODT says it can detect cervical cancer more accurately and inexpensively than the standard colposcopy method used today, by creating a mobile digital colposcope made up of a smartphone equipped with a light source, a lens for magnification and an artificial intelligence algorithm. A colposcopy is a procedure that uses a colpocope that provides doctors with an illuminated and magnified view of a woman ’s cervix and the tissues of the vagina and vulva, to screen for cervical cancer. In 2018, 570,000 women were diagnosed with cervical cancer worldwide, making it the fourth most frequent cancer in females, according to the World Health Organization. A research by the National Cancer Institute also showed that 80 percent of the cases and 90% of the 280,000 deaths occurred in low- and middle-income countries, where the number of qualified colposcopists — the specialists who deal with the screenings of this anatomical area — is lower and healthcare operators have fewer resour...
Source: Lab Soft News - Category: Laboratory Medicine Authors: Source Type: blogs

Related Links:

This article provides recommendations to help pediatric and family practice providers increase rates of uptake of the HPV vaccine among adolescent patients, including communication strategies, and practice improvements that encourage vaccination.
Source: The Journal for Nurse Practitioners - Category: Nursing Authors: Tags: Featured Article Source Type: research
Human papillomavirus (HPV) is responsible for approximately 570  000 cases of cervical cancer worldwide every year. Most of these cases of cancer could be prevented, either through early vaccination against high-risk HPV, or by successful screening and management of precursors of cervical cancer. Although childhood vaccination against HPV would be ideal, most women have not received the HPV vaccination and screening for precancerous lesions is generally effective, as long as abnormal results are effectively managed. Despite years of screening, it is still estimated that 13 000 cases of cervical cancer will occur in the...
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research
Prevention is often called the best medicine — but research has shown that millions of Americans are not getting the preventive care they should to live long, healthy lives. Obstacles like inadequate access to care and financial barriers can keep people away from the doctor, but anxiety and feeling like care is unnecessary are also common deterrents. “There are a lot of things that every person could do to stay healthy, and this could help people to feel better, improve their quality of life and help them to live longer,” says Dr. Alex Krist, a professor of family medicine at Virginia Commonwealth Univer...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Longevity public health Source Type: news
(Reuters Health) - - Young women who received human papillomavirus (HPV) vaccines as adolescents had significantly lower rates of a condition that's a precursor to cervical cancer, in a nationwide study in Scotland.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
In this study it was assumed that there was no immunity following resolution of natural infection. The modeling demonstrated that a vaccine of moderate efficacy could have a significant impact on the prevalence of gonorrhea if strategically implemented (23). While encouraging it does, of course, depend on the availability of a vaccine. From Ecological Data to Evidence The epidemiological evidence from Cuba, Brazil, and New Zealand demonstrates that N. meningitidis OMV vaccines are possibly able to provide some broader protection against meningococcal disease (17, 24), particularly in older children and adults (25). These...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
The human papillomavirus (HPV) vaccine, first developed to help guard against cervical cancer, also seems to protect against a rare, chronic childhood respiratory disease.
Source: WebMD Health - Category: Consumer Health News Source Type: news
THURSDAY, Nov. 9, 2017 -- The human papillomavirus (HPV) vaccine, first developed to help guard against cervical cancer, also seems to protect against a rare, chronic childhood respiratory disease, a new study suggests. It's believed that the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Anti-vaccine advocate Robert F. Kennedy Jr. said that President-elect Donald Trump asked him to lead a new government commission on vaccine safety. But science on this issue is already clear; numerous studies show that vaccines are safe and effective, and that serious side effects are rare. On Jan. 10, Kennedy met with the president-elect at Trump Tower, and later told reporters about the new commission. However, the Trump administration did not confirm that such a commission was in the works. A spokesperson for Trump said only that the president-elect was “exploring the possibility of forming a committee on autism,&...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
Human papillomavirus (HPV) is the most common cause of cervical cancer worldwide, and Romania has the highest rate of cervical cancer in Europe. Sixty-five young Romanian women infected with HIV during early childhood and 25 control subjects were evaluated for the presence of cervical HPV infection and for cytologic abnormalities. HPV infection was evaluated longitudinally in 42 HIV-infected individuals. Overall 28/65 (43.1%) of HIV-infected and 8/25 (32.0%) of uninfected subjects were infected with HPV, and 21/65 (32.3%) and 6/25 (24%) had high-risk subtypes, respectively. In HIV-infected women, those maintaining or acqui...
Source: International Journal of STD and AIDS - Category: Global & Universal Authors: Tags: Original research articles Source Type: research
Key content An organised screening programme has reduced the incidence of cervical cancer in the UK. Cervical screening aims to detect and treat premalignant, low‐ or high‐grade disease. Oncogenic or high‐risk human papillomaviruses (HR‐HPV) account for over 99.7% of cervical cancer cases; the most common subtypes are HPV‐16, 18, 31, 33 and 45. HPV vaccination was introduced as part of the childhood vaccination programme in 2008 and will probably save 400 lives per year. HPV testing is useful: in triage of women with borderline or low‐grade cytology; as a test of cure after treatment, in the management of ...
Source: The Obstetrician and Gynaecologist - Category: OBGYN Authors: Tags: Review Source Type: research
More News: Biomedical Engineering | Cambodia Health | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Child Development | Childhood Cancer | Colposcopy | Cytology | Databases & Libraries | Electronic Medical Records (EMR) | Forensic Medicine | Funding | Genital Warts | Hospitals | HPV Testing | Human Papillomavirus (HPV) | India Health | International Medicine & Public Health | Internet | Israel Health | Kenya Health | Laboratory Medicine | Middle East Health | Papanicolaou (Pap) Smear | Study | Teaching | Ultrasound | Universities & Medical Training | Vaccines | WHO | Women